Galectin Therapeutics Financials - Benzinga

Galectin Therapeutics Inc

GALTNASDAQ

Trade with Public

Trade with Public

$4.02

-0.12-2.9%

At close: Aug 28, 5:00 PM EST

$4.27

0.256.16%

After Hours: Aug 27, 8:33 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Galectin Therapeutics Financials

Galectin Therapeutics (GALT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Galectin Therapeutics Q2 EPS $(0.14) Misses $(0.09) Estimate

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.09) by 55.56 percent. This is a 16.67 percent decrease over losses of $(0.12) per

Benzinga Newsdesk

PRO
Galectin Therapeutics Q1 EPS $(0.08) Misses $(0.06) Estimate

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 46.67 percent increase over losses of $(0.15) per

Benzinga Newsdesk

PRO
Galectin Therapeutics Q4 EPS $(0.08) Beats $(0.11) Estimate

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.11) by 27.27 percent. This is a 57.89 percent increase over losses of $(0.19) per share

Benzinga Newsdesk

PRO
Galectin Therapeutics Q2 EPS $(0.12) Beats $(0.16) Estimate

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.16) by 25 percent. This is a 40 percent increase over losses of $(0.20) per share from

Benzinga Newsdesk

PRO
Galectin Therapeutics Q1 EPS $(0.15) Beats $(0.20) Estimate

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.20) by 25 percent. This is a 21.05 percent increase over losses of $(0.19) per share

Benzinga Newsdesk

PRO
Galectin Therapeutics FY 2024 GAAP EPS $(0.76) Misses $(0.73) Estimate, Cash Balance Of $15.1M

Benzinga Newsdesk